Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

ISSN： 1460-2350

Source： Human Reproduction, Vol.17, Iss.10, 2002-10, pp. : 2501-2508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Meta‐analysis of recombinant FSH and urinary‐derived gonadotrophins for IVF or ICSI

By Al‐Inany Hesham

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1555-1556

Oxford University Press

Access to resources Recommend Favorite

Prions, urinary gonadotrophins and recombinant gonadotrophins

By Matorras Roberto Rodríguez‐Escudero Francisco Javier

Human Reproduction, Vol. 18, Iss. 5, 2003-05 ,pp. : 1129-1130

Oxford University Press

Access to resources Recommend Favorite

Meta‐analysis of recombinant versus urinary‐derived FSH: an update

By Al‐Inany Hesham Aboulghar Mohamed Mansour Ragaa Serour Gamal

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt–Jakob disease

By Balen Adam H. Lumholtz Ib Bo

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 2994-2999

Oxford University Press

Access to resources Recommend Favorite

What are the clinical benefits of recombinant gonadotrophins?

By Out Henk J.

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2189-2190

Oxford University Press

Access to resources Recommend Favorite